Federated Hermes’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.79M | Sell |
3,309
-144
| -4% | -$81.1K | ﹤0.01% | 1033 |
|
|
2026
Q1 | $2.05M | Sell |
3,453
-41
| -1% | -$20.4K | ﹤0.01% | 973 |
|
|
2025
Q4 | $1.7M | Sell |
3,494
-579
| -14% | -$270K | ﹤0.01% | 995 |
|
|
2025
Q3 | $1.71M | Sell |
4,073
-173
| -4% | -$58.2K | ﹤0.01% | 980 |
|
|
2025
Q2 | $1.22M | Sell |
4,246
-470
| -10% | -$140K | ﹤0.01% | 1077 |
|
|
2025
Q1 | $1.45M | Sell |
4,716
-2,362
| -33% | -$809K | ﹤0.01% | 1015 |
|
|
2024
Q4 | $2.5M | Buy |
7,078
+305
| +5% | +$112K | 0.01% | 886 |
|
|
2024
Q3 | $2.43M | Sell |
6,773
-117
| -2% | -$39.5K | 0.01% | 887 |
|
|
2024
Q2 | $2.19M | Sell |
6,890
-733
| -10% | -$194K | 0.01% | 903 |
|
|
2024
Q1 | $1.75M | Sell |
7,623
-76
| -1% | -$17.1K | ﹤0.01% | 972 |
|
|
2023
Q4 | $1.69M | Sell |
7,699
-916
| -11% | -$211K | ﹤0.01% | 996 |
|
|
2023
Q3 | $1.95M | Sell |
8,615
-364
| -4% | -$83.8K | 0.01% | 928 |
|
|
2023
Q2 | $1.98M | Sell |
8,979
-34
| -0.4% | -$7.53K | ﹤0.01% | 951 |
|
|
2023
Q1 | $2.02M | Buy |
9,013
+24
| +0.3% | +$5.92K | 0.01% | 955 |
|
|
2022
Q4 | $2.5M | Sell |
8,989
-3,454
| -28% | -$872K | 0.01% | 847 |
|
|
2022
Q3 | $2.61M | Sell |
12,443
-74
| -0.6% | -$16.5K | 0.01% | 843 |
|
|
2022
Q2 | $2.95M | Sell |
12,517
-1,086
| -8% | -$221K | 0.01% | 826 |
|
|
2022
Q1 | $2.44M | Buy |
13,603
+61
| +0.5% | +$11.6K | 0.01% | 987 |
|
|
2021
Q4 | $2.93M | Buy |
13,542
+121
| +0.9% | +$23.8K | 0.01% | 956 |
|
|
2021
Q3 | $2.48M | Buy |
13,421
+412
| +3% | +$81.2K | ﹤0.01% | 984 |
|
|
2021
Q2 | $2.33M | Sell |
13,009
-5,909
| -31% | -$1.13M | ﹤0.01% | 1041 |
|
|
2021
Q1 | $3.17M | Sell |
18,918
-684
| -3% | -$114K | 0.01% | 977 |
|
|
2020
Q4 | $2.98M | Buy |
19,602
+148
| +0.8% | +$19.4K | 0.01% | 945 |
|
|
2020
Q3 | $1.97M | Sell |
19,454
-190
| -1% | -$20.8K | ﹤0.01% | 995 |
|
|
2020
Q2 | $2.38M | Buy |
19,644
+7,953
| +68% | +$895K | 0.01% | 938 |
|
|
2020
Q1 | $1.11M | Sell |
11,691
-1,499
| -11% | -$142K | ﹤0.01% | 1105 |
|
|
2019
Q4 | $1.16M | Buy |
13,190
+2,791
| +27% | +$246K | ﹤0.01% | 1223 |
|
|
2019
Q3 | $829K | Sell |
10,399
-245
| -2% | -$19.7K | ﹤0.01% | 1342 |
|
|
2019
Q2 | $831K | Sell |
10,644
-4,168
| -28% | -$390K | ﹤0.01% | 1339 |
|
|
2019
Q1 | $1.74M | Buy |
14,812
+1,803
| +14% | +$210K | ﹤0.01% | 1103 |
|
|
2018
Q4 | $1.42M | Sell |
13,009
-4,231
| -25% | -$491K | ﹤0.01% | 1158 |
|
|
2018
Q3 | $2.21M | Sell |
17,240
-619
| -3% | -$76.6K | 0.01% | 1062 |
|
|
2018
Q2 | $2.02M | Buy |
17,859
+33
| +0.2% | +$3.63K | 0.01% | 1009 |
|
|
2018
Q1 | $2M | Buy |
17,826
+460
| +3% | +$58.4K | 0.01% | 957 |
|
|
2017
Q4 | $2.57M | Sell |
17,366
-6,632
| -28% | -$843K | 0.01% | 835 |
|
|
2017
Q3 | $2.81M | Buy |
23,998
+1,361
| +6% | +$174K | 0.01% | 772 |
|
|
2017
Q2 | $2.94M | Sell |
22,637
-28,377
| -56% | -$3.54M | 0.01% | 747 |
|
|
2017
Q1 | $6.91M | Sell |
51,014
-152,595
| -75% | -$23.1M | 0.02% | 497 |
|
|
2016
Q4 | $29.2M | Sell |
203,609
-23,800
| -10% | -$3.04M | 0.09% | 192 |
|
|
2016
Q3 | $26.9M | Sell |
227,409
-20,147
| -8% | -$2.42M | 0.08% | 206 |
|
|
2016
Q2 | $26.2M | Buy |
247,556
+4,097
| +2% | +$457K | 0.08% | 208 |
|
|
2016
Q1 | $27.1M | Buy |
243,459
+51,852
| +27% | +$6.56M | 0.08% | 205 |
|
|
2015
Q4 | $30M | Buy |
191,607
+118,326
| +161% | +$17.2M | 0.1% | 205 |
|
|
2015
Q3 | $9.62M | Sell |
73,281
-67,157
| -48% | -$10.8M | 0.03% | 442 |
|
|
2015
Q2 | $24.4M | Sell |
140,438
-14,564
| -9% | -$2.62M | 0.07% | 278 |
|
|
2015
Q1 | $26.7M | Buy |
155,002
+57,475
| +59% | +$8.76M | 0.08% | 237 |
|
|
2014
Q4 | $12.6M | Buy |
97,527
+5,067
| +5% | +$653K | 0.04% | 395 |
|
|
2014
Q3 | $11.9M | Sell |
92,460
-4,206
| -4% | -$434K | 0.04% | 394 |
|
|
2014
Q2 | $8.55M | Sell |
96,666
-10,251
| -10% | -$986K | 0.03% | 494 |
|
|
2014
Q1 | $10.1M | Buy |
106,917
+13,027
| +14% | +$1.33M | 0.03% | 461 |
|
|
2013
Q4 | $10.6M | Sell |
93,890
-44
| -0% | -$3.97K | 0.04% | 432 |
|
|
2013
Q3 | $7.41M | Sell |
93,934
-596
| -0.6% | -$43.6K | 0.03% | 461 |
|
|
2013
Q2 | $6.22M | Buy |
+94,530
| New | +$6.09M | 0.02% | 511 |
|
Other funds holding UTHR
ACA
JT
Federated Hermes's UTHR Position: Q2 2026 in Review
Federated Hermes reduced its United Therapeutics (UTHR) stake by 4.2% in Q2 2026, selling an estimated $81.1K and leaving 3,309 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.
Federated Hermes first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $30M in Q4 2015. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Federated Hermes held 3,309 shares of United Therapeutics worth $1.79M as of Q2 2026.
- Federated Hermes sold 144 United Therapeutics shares in Q2 2026, an estimated $81.1K.
- United Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1033 holding.
- Federated Hermes first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's United Therapeutics position peaked at $30M in Q4 2015.
- 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.